JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
0.4
Cite Score
SJR: 0.114 / SNIP: 0.090
Volume 15, Issue 3 (2023)
Iran J War Public Health 2023, 15(3): 311-314 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2023/05/15 | Accepted: 2023/07/3 | Published: 2023/07/15
Received: 2023/05/15 | Accepted: 2023/07/3 | Published: 2023/07/15
How to cite this article
Jaber T. Relationship of Serum Lipids Levels with Erythrocyte Sedimentation Rate in Female Type 2 Diabetic Mellitus Patients. Iran J War Public Health 2023; 15 (3) :311-314
URL: http://ijwph.ir/article-1-1357-en.html
URL: http://ijwph.ir/article-1-1357-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Authors
T.F. Jaber *
Scientific Affairs Department, Faculty of Education, Mustansiriyah University, Baghdad, Iraq
Abstract (809 Views)
Aims: Type 2 diabetes is a major public health threat that affects millions of people worldwide, particularly women. This study aimed to investigate the correlation between serum lipid levels and erythrocyte sedimentation rate in female patients with type 2 diabetes.
Materials & Methods: This retrospective experimental study was conducted at Al-Karkh Private Laboratory, Baghdad, Iraq, from 3 July 2022 to 8 March 2023 in female patients records who were diagnosed with type 2 diabetes. Fifty-nine type 2 diabetes patients and 23 healthy individuals were selected using the appropriate sampling method. Data was collected from medical records and laboratory results of the patients. The relationship of serum lipids and erythrocyte sedimentation rate with diabetes was evaluated using an independent sample T-test.
Findings: Patients with higher ESR, VLDL, LDL, TG, or total cholesterol levels had lower HDL levels, indicating a correlation with type 2 diabetes. There were significant differences between the two groups of diabetic patients and healthy individuals below and over 30 in every parameter except HDL.
Conclusion: Increased levels of very-low-density lipoprotein are associated with an increased risk of type 2 diabetes and coronary heart disease. High levels of low-density lipoprotein are associated with an increased risk of heart disease and diabetes.
Materials & Methods: This retrospective experimental study was conducted at Al-Karkh Private Laboratory, Baghdad, Iraq, from 3 July 2022 to 8 March 2023 in female patients records who were diagnosed with type 2 diabetes. Fifty-nine type 2 diabetes patients and 23 healthy individuals were selected using the appropriate sampling method. Data was collected from medical records and laboratory results of the patients. The relationship of serum lipids and erythrocyte sedimentation rate with diabetes was evaluated using an independent sample T-test.
Findings: Patients with higher ESR, VLDL, LDL, TG, or total cholesterol levels had lower HDL levels, indicating a correlation with type 2 diabetes. There were significant differences between the two groups of diabetic patients and healthy individuals below and over 30 in every parameter except HDL.
Conclusion: Increased levels of very-low-density lipoprotein are associated with an increased risk of type 2 diabetes and coronary heart disease. High levels of low-density lipoprotein are associated with an increased risk of heart disease and diabetes.
Keywords:
References
1. Ji XW, Feng GF, Li HL, Fang J, Wang J, Shen QM, et al. Gender differences of relationship between serum lipid indices and type 2 diabetes mellitus: A cross-sectional survey in Chinese elderly adults. Ann Transl Med. 2021;9(2). [Link] [DOI:10.21037/atm-20-2478]
2. Khan MAB, Hashim MJ, King JK, Govender RD, Al Kaabi J. Epidemiology of type 2 diabetes - Global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10(1):107-11. [Link] [DOI:10.2991/jegh.k.191028.001]
3. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, ho NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40-50. [Link] [DOI:10.1016/j.diabres.2017.03.024]
4. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-1053. [Link] [DOI:10.2337/diacare.27.5.1047]
5. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2015;38:S8-16. [Link] [DOI:10.2337/dc15-S005]
6. American Diabetes Association. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2020. Diabetes Care. 2020;43(1):S14-31. [Link] [DOI:10.2337/dc20-S002]
7. Viigimaa M, Sachinidis A, Toumpourleka M, Koutsampasopoulos K, Alliksoo S, Titma T (2020). Macrovascular complications of type 2 diabetes mellitus. Curr Diabetes Rev. 18(2):110-6. [Link] [DOI:10.2174/1570161117666190405165151]
8. Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. J Am Med Assoc. 2017;317(24):2515-23. [Link] [DOI:10.1001/jama.2017.7596]
9. Tishkowski K, Gupta V. Erythrocyte Sedimentation Rate. Bethesda: National Library of Medicine; 2023. [Link]
10. Jialal I, Singh G. Management of diabetic dyslipidemia: An update. World J Diabetes. 2019;10:280-90. [Link] [DOI:10.4239/wjd.v10.i5.280]
11. Liu L, Guan X, Yuan Z, Zhao M, Li Q, Zhang X, et al. Different contributions of dyslipidemia and obesity to the natural history of type 2 diabetes: 3-Year cohort study in China. J Diabetes Res. 2019;2019:4328975. [Link] [DOI:10.1155/2019/4328975]
12. Zhang M, Zhou J, Liu Y, Sun X, Luo X, Han C, et al. Risk of type 2 diabetes mellitus associated with plasma lipid levels: The rural Chinese cohort study. Diabetes Res Clin Pract. 2018;135:150-7. [Link] [DOI:10.1016/j.diabres.2017.11.011]
13. Rizzo M, Rini GB, Berneis K. The clinical relevance of LDL size and subclasses modulation in patients with type-2 diabetes. Exp Clin Endocrinol Diabetes. 2007;115(8):477-82. [Link] [DOI:10.1055/s-2007-980179]
14. Kruit JK, Brunham LR, Verchere CB, Hayden MR, et al. HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitus. Curr Opin Lipidol. 2010;21(3):178-85. [Link] [DOI:10.1097/MOL.0b013e328339387b]
15. Cochran BJ, Ong KL, Manandhar B, Rye KA. High Density Lipoproteins and Diabetes. Cells. 2021:10(4);850. [Link] [DOI:10.3390/cells10040850]
16. Sheng G, Liu D, Kuang M, Zhong Y, Zhang S, Zou Y. Utility of non-high density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in evaluating incident diabetes risk. Diabetes Metab Syndr Obes: Targets Ther. 2022;15:1677-86. [Link] [DOI:10.2147/DMSO.S355980]
17. Wu D, Lan Y, Xu Y, Xu S, Huang Y, Balmer L, et al. Association of cumulative monocytes to high-density lipoprotein ratio with the risk of type 2 diabetes: a prospective cohort study. Cardiol Diabetol. 2022;21(1):268. [Link] [DOI:10.1186/s12933-022-01701-7]
18. Ishibashi T, Kaneko H, Matsuoka S, Suzuki Y, Ueno K, Ohno R, et al. HDL cholesterol and clinical outcomes in diabetes mellitus: A systematic review and meta-analysis. Eur J Prev Cardiol. 2023;30(8):646-53. [Link] [DOI:10.1093/eurjpc/zwad029]
19. Wang Y, Yang P, Yan Z, Liu Z, Ma Q, Zhang Z, et al. The relationship between erythrocytes and diabetes mellitus. J Diabetes Res. 2021:6656062. [Link] [DOI:10.1155/2021/6656062]
20. Kiyani MM, Jahan S, Kiani SK, Rehman H, Khan LG, Iqbal U. Erythrocyte sedimentation rate in diabetic and non-diabetic patients of cardiovascular disease. J Technol Lab. 2019;8(1):18-22. [Link] [DOI:10.29238/teknolabjournal.v8i1.159]
21. Kaleta JL, Fleischli JW, Reilly CH. The diagnosis of osteomyelitis in diabetes using erythrocyte sedimentation rate: A pilot study. J Am Podiatr Med Assoc. 2001;9(9):445-50. [Link] [DOI:10.7547/87507315-91-9-445]
22. Guo S, Wang M, Yu Y, Yang Y, Zeng , Sun F, et al. The association of erythrocytes sedimentation rate, high-sensitivity creativity protein and diabetic kidney disease in patients with type 2 diabetes. BMC Endocr Disord. 2020;13(20):103. [Link] [DOI:10.1186/s12902-020-00584-7]
23. Feng Q, Wei WQ, Chung CP, Levinson RT, Sondermann AC, Mosley JD, et al. Relationship between very low low-density lipoprotein cholesterol concentrations not due to statin therapy and risk of type 2 diabetes: A US-based cross-sectional observational study using electronic health records. PLOS Med. 2018;15(8):e1002642. [Link] [DOI:10.1371/journal.pmed.1002642]
24. Janghorbani M, Soltanian N, Amini M, Aminorroaya A. Low-density lipoprotein cholesterol and risk of type 2 diabetes: The Isfahan Diabetes Prevention Study. Diabetes Metab Syndr: Clin Res Rev. 2010;12(5):715-19. [Link] [DOI:10.1016/j.dsx.2018.04.019]
25. Prenner SB, Mulvey CK, Ferguson JF, Rickels MR, Bhatt AB, Reilly MP. Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglycerides. Atherosclerosis. 2014;236(2):321-26. [Link] [DOI:10.1016/j.atherosclerosis.2014.07.008]
26. Jin JL, Zhang HW, Cao YX, Liu HH, Hua Q, Li YF, et al. Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational one cohort study. Cardiovasc Diabetol. 2020;19(1):45. [Link] [DOI:10.1186/s12933-020-01015-6]
27. Ye X, Kong W, Zafar MI, Chen LL. Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Cardiovasc Diabetol. 2019;18(48). [Link] [DOI:10.1186/s12933-019-0851-z]
28. Beshara A, Cohen E, Goldberg E, Lilos P, Garty M, Krause I. Triglyceride levels and risk of type 2 diabetes mellitus: A longitudinal large study. J Investig Med. 2016;64(2).383-7. [Link] [DOI:10.1136/jim-2015-000025]
29. Su WY, Chen SC, Huang YT, Huang JC, Wu PY, Hsu WH, et al. Comparison of the effects of fasting glucose, hemoglobin A1c, and triglyceride-glucose index on cardiovascular events in type 2 diabetes mellitus. Nutrients. 2019;11(11):2838. [Link] [DOI:10.3390/nu11112838]
30. Zheng D, Dou J, Liu G, Pan Y, Yan Y, Liu F, et al. Association between triglyceride level and glycemic level control among insulin-treated patients with type 2 diabetes. J Clin Endocrinol Metab. 2019;104(4):1211-20. [Link] [DOI:10.1210/jc.2018-01656]
31. Simonen PP, Gylling HK, Miettinen TA. Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care. 2002;25(9):1511-15. [Link] [DOI:10.2337/diacare.25.9.1511]
32. Rhee EJ, Han K, Ko SH, Ko KS, Lee WY. Increased risk for diabetes development in subjects with large variation in total cholesterol levels in 2,827,950 Koreans: A nationwide population-based study. PLoS ONE. 2017;12(5):e0176615. [Link] [DOI:10.1371/journal.pone.0176615]
33. Li Y, Pei H, Zhou C, Lou Y. Dietary cholesterol consumption and incidence of type 2 diabetes mellitus: A dose-response meta-analysis of prospective cohort studies. Nutr Metab Cardiovasc Dis. 2023;33(1):2-10. [Link] [DOI:10.1016/j.numecd.2022.07.016]
34. Peng J, Zhao F, Yang X, Pan X, Xin J, Wu M, et al. Association between dyslipidemia and risk of type 2 diabetes mellitus in middle-aged and older Chinese adults: a secondary analysis of a nationwide cohort. BMJ Open. 2021;11(5):e042821. [Link] [DOI:10.1136/bmjopen-2020-042821]